Microsoft Partners with Pangaea Data to Decode Doctor-Patient Dialogue with AI

Pangaea Data has announced a partnership with Microsoft to enhance electronic health record (EHR) workflows using artificial intelligence. The collaboration will combine Microsoft’s Dragon Copilot—which incorporates natural language speech, ambient listening, and generative AI—with Pangaea’s AI reasoning capabilities to convert live doctor-patient conversations into actionable clinical insights.

Pangaea’s AI platform currently analyses patient data to identify care gaps, especially in populations with hard-to-diagnose conditions. Its cognitive computing model interprets EHRs in line with established clinical guidelines and can be embedded into existing clinical systems. The addition of Dragon Copilot’s real-time conversational analysis will allow the system to listen to clinical interactions and capture critical information as it happens. These insights will support clinicians by automating and prioritising next steps such as follow-up scheduling, updating notes, and refining treatment plans.

“By connecting Pangaea Data's platform capabilities with Microsoft Dragon Copilot, we will allow clinicians to focus on their patients while the AI surfaces the insights they need, all without disrupting their existing workflows,” said Vibhor Gupta, founder and CEO of Pangaea. He added, “The integration will reduce the burden of note-taking, ensure critical insights aren't overlooked and help deliver more timely and equitable care.”

The partnership aims to reveal hidden trends and social determinants within EHR data, supporting faster diagnoses and more personalised, equitable care. This approach reflects a growing industry focus on embedding AI-driven tools within routine healthcare delivery to optimise clinician efficiency.

Pangaea has previously collaborated with Mersey Care NHS Foundation Trust and the University of Liverpool to better characterise patients with complex mental health conditions. It has also worked with Topcon Healthcare to address eye health challenges and with AstraZeneca’s subsidiary Alexion to develop an AI decision support system for detecting hypophosphatasia.

The announcement follows Pangaea’s official platform launch earlier this week and comes shortly after Microsoft unveiled new AI enhancements for Dragon Copilot designed to extend its capabilities into nursing workflows.

Click here for the original news story.